What Are the Opportunities in Clinical Laboratory Instrumentation & Reagent Markets?
Research and Markets (http://www.researchandmarkets.com/reports/c52648) has announced the addition of Clinical Laboratory Testing Volume 1: Reagents and Instruments to their offering.
Clinical laboratory analysis for in vitro diagnostic (IVD) testing is one of the most important sectors of medical care. By all accounts, it is very mature, large and diverse–crossing the $33 billion mark in 2006–and employing over 100,000 laboratory workers, and spawning an industry for reagents and instruments comprised of thousands of companies worldwide. The term clinical laboratory analysis usually refers to determining the concentration or activity of a protein, carbohydrate, lipid, electrolyte, enzyme or small molecule in easily collected body fluids such as blood, serum, plasma or urine. However, it is not necessarily limited to these determinations.
The purpose of this report is to describe the specific segments of the global clinical laboratory instrumentation and reagent market. Within this area, the report covers those segments that are highly active in terms of innovation and growth. Specifically, this global clinical laboratory markets report examines the markets for small lab equipment all the way up to highly-automated, large lab platforms, as well as accessory equipment such as reagents, supplies and manufacturers’ original equipment manufacturer (OEM) additional equipment.
The emphasis in this analysis is on those companies and products that are actively developing and marketing laboratory analyzer products for the clinical setting, including hospitals, independent labs, physician’s offices and miscellaneous clinics. This study concentrates on the clinical laboratory instrumentation industry market segment and the companion reagents sector in the U.S. and around the world.
The regional markets and their differences are examined, including Europe, Asia (Japan, China and India) and the rest of the world (ROW). Particular attention is paid to those areas of the clinical laboratory instrumentation and reagents sector that are showing the greatest growth or the most innovation.
This report attempts to answer the following questions:
– Which companies are the key players?
– What are the opportunities in clinical laboratory instrumentation and reagent markets?
– What is happening with the information revolution in lab instruments?
– What are the developing trends?
– Where are the new market growth areas?
– What are the most favored lab analysis technology platforms?
– Where is the laboratory analyzer instrument technology taking us?
– How is immunological technology blending with more established laboratory procedures?
– What are the business trends in the IVD industry?
The unique benefits of this report are:
– In-depth analysis of the major sectors of the clinical laboratory instrumentation and reagent sectors, their size, growth rates and major drivers.
– Presentation of some of the emerging technology platforms, elucidating the potential areas that could gain traction in this market.
– Analysis of the partnerships and alliances the various key sector players have forged, as well as describing financings of these market participants, giving insight into potential market collaborations.
– Examination of new technology platforms in the U.S., Japan and Europe that seek to dominate this mature market, and to identify lead positions and potential future growth areas.
Topics Covered
1. Overview
2. IVD Clinical Laboratory Market
3. IVD Clinical Laboratory Market
4. Clinical Laboratory Instrument Market by Sector
5. Important Technology Trends in IVD Instrumentation and Reagents
6. Business Trends in the Clinical Laboratory Analyzer and Reagents Market
7. Company Profiles
List of Figures
List of Tables
Companies Mentioned
– Abaxis
– Abbott Diagnostics
– Adaltis, Inc.
– Alfa Wasserman, Inc. (formerly Electro-Nucleonics, Inc. and Schiapparelli Biosystems, Inc.)
– Awareness Technology
– Bayer Diagnostics
– Beckman Coulter, Inc.
– Bio-Reference Laboratories, Inc.
– Clarient, Inc.
– Dade Behring, Inc.
– Enzo Biochem, Inc.
– Genomic Health, Inc.
– Hitachi
– Horiba Ltd.
– JEOL Ltd.
– LabCorp
– Medtox Scientific, Inc.
– Monogram Biosciences, Inc.
– Myriad Genetics, Inc.
– Nova Biomedical
– Olympus America, Inc. Diagnostic Systems Division
– Ortho-Clinical Diagnostics, a J&J Company
– Psychemedics Corporation
– Quest Diagnostics, Inc.
– Roche Diagnostics Corp.
– Shimadzu
– Sysmex Corporation
– Thermo Fisher Scientific, Inc.
– Vital Scientific, NV
For more information visit http://www.researchandmarkets.com/reports/c52648